Android Apple

Swelling losses haven't held back gains for Agios Pharmaceuticals (NASDAQ:AGIO) shareholders since they're up 71% over 1 year

By Yahoo! Finance   |   6 months ago
Swelling losses haven't held back gains for Agios Pharmaceuticals (NASDAQ:AGIO) shareholders since they're up 71% over 1 year

Passive investing in index funds may match market returns, but selecting high-performing stocks can outperform. Agios Pharmaceuticals (NASDAQ: AGIO) shares surged 71% in the last year, driven by a 55% revenue growth.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.